Pharmacogenomics and personalised medicine

The following session will cover pharmacogenomics and personalized medicine within the context of this subject, focusing on pharmacogenomics and its role in shifting medicine towards personalized treatments by considering individual genetic differences in drug response. We will discuss how advances in genomics enable tailored drug selection and dosing, the importance of genetic variants and biomarkers and examples of pharmacogenomics in clinical practice. The presentation will also address current challenges, including equity, ethical considerations, and implementation barriers that impact the integration of pharmacogenomics into routine care. Ultimately, we'll highlight how personalized medicine is reshaping health care with the promise of safer and more effective therapies. We will explore pharmacogenomics and its impact on personalized medicine. Pharmacogenomics studies how a person's genetic makeup influences their response to medications, shifting from a one size fits all model to therapies tailored to each patient's genetics. This recognizes that genetic diversity affects drug efficacy and adverse effects. Advances in genomic technology now allow clinicians to better integrate genetics into decision making, aiming to optimize drug choice and dosing for each patient. Drug response varies widely between individuals with genetic differences playing a significant role. Genes encoding drug metabolizing enzymes, transporters and targets often show notable polymorphisms. For instance, variations in cytochrome P 450 enzymes,